Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.

OBJECTIVE To determine the outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients treated with chemotherapy for gestational trophoblastic tumor. METHODS Retrospective record review of patients with gestational trophoblastic tumor who conceived before standard hCG follow-up was completed during 1973-1998. RESULTS Forty-three patients treated for gestational trophoblastic tumors conceived before human chorionic gonadotropin follow-up was completed. The antecedent pregnancy was complete mole in 31 (72.1%) and partial mole in 12 (27. 9%) patients. Of the 43 patients, 39 (90.7%) had stage I, 1 had stage II, and 3 had stage III disease. The mean interval from human chorionic gonadotropin remission to new pregnancy was 6.3 months (range 1-11 months). Ten patients underwent elective termination and four patients were lost to follow-up. Of the remaining 29 patients, 22 (75.9%) had term live births, 3 (10.3%) had preterm delivery, 3 had spontaneous abortion, and 1 (3.5%) had a repeat mole. Two cases of fetal anomalies were detected; one was inherited polydactyly and the other was hydronephrosis. One patient developed choriocarcinoma with lung involvement and underwent cesarean section at 28 weeks; a normal fetus was delivered and no choriocarcinoma was detected in the placenta. CONCLUSION Pregnancies occurring in patients treated for gestational trophoblastic tumor before standard human chorionic gonadotropin follow-up is completed may continue under close clinical surveillance since the majority have a favorable outcome. However, patients should also be advised of the low but important risk of delayed diagnosis in case tumor relapse develops during early subsequent pregnancy.

[1]  R. Woolas,et al.  Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome , 1998, British journal of obstetrics and gynaecology.

[2]  A. Sood,et al.  The use of chemotherapeutic agents during pregnancy. , 1997, Obstetrics and gynecology clinics of North America.

[3]  R. Berkowitz,et al.  The psychological, social, and sexual consequences of gestational trophoblastic disease. , 1992, Gynecologic oncology.

[4]  V. Sivanesaratnam,et al.  Normal pregnancy after successful treatment of choriocarcinoma with cerebral metastases. A case report. , 1988, The Journal of reproductive medicine.

[5]  P. Wu,et al.  Pregnancy outcomes after successful chemotherapy for choriocarcinoma and invasive mole: long-term follow-up. , 1988, American journal of obstetrics and gynecology.

[6]  H. Ngan,et al.  Reproductive Performance of Patients with Gestational Trophoblastic Disease in Hong Kong , 1988 .

[7]  F. Hsieh,et al.  The outcome of pregnancy after chemotherapy for gestational trophoblastic disease. , 1986, Biological research in pregnancy and perinatology.

[8]  G. Rustin,et al.  Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours. , 1984, British medical journal.

[9]  D. B. Reddy,et al.  Experimental production of cancer with tobacco tar and heat , 1960, Cancer.

[10]  S. Charache,et al.  Studies on the folic acid vitamins. IV. The persistence of amethopterin in mammalian tissues , 1960, Cancer.

[11]  R. Berkowitz,et al.  Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. , 1998, The Journal of reproductive medicine.

[12]  R. Berkowitz,et al.  Reproductive outcome after methotrexate treatment of tubal pregnancies. , 1998, The Journal of reproductive medicine.

[13]  R. Berkowitz,et al.  Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy. , 1998, The Journal of reproductive medicine.